HAP Trading’s AstraZeneca AZN Stock Holding History

HAP Trading’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-79,650	Closed	-$65K	–	1187
2022 Q4	$65K	Buy	79,650 +350	+0.4%	+$43.9K	0.01%	681
2022 Q3	$333K	Buy	79,300 +800	+1%	+$101K	0.02%	441
2022 Q2	$220K	Sell	78,500 -300	-0.4%	-$39.4K	0.01%	695
2022 Q1	$235K	Sell	78,800 -20,208	-20%	-$2.42M	0.01%	785
2021 Q4	$426K	Buy	99,008 +2,132	+2%	+$251K	0.01%	749
2021 Q3	$387K	Buy	96,876 +12,776	+15%	+$1.49M	0.01%	762
2021 Q2	$314K	Buy	84,100 +64,200	+323%	+$7.04M	0.01%	812
2021 Q1	$141K	Sell	19,900 -800	-4%	-$80.4K	0.01%	851
2020 Q4	$298K	Buy	20,700 +4,350	+27%	+$461K	0.01%	816
2020 Q3	$180K	Sell	16,350 -12,550	-43%	-$1.4M	0.01%	662
2020 Q2	$97K	Buy	+28,900	New	+$2.98M	0.01%	864
2017 Q3	–	Sell	-564,000	Closed	-$284K	–	892
2017 Q2	$284K	Buy	564,000 +555,400	+6,458%	+$36.3M	0.02%	458
2017 Q1	$3K	Buy	+8,600	New	+$501K	﹤0.01%	977
2015 Q3	–	Sell	-13,900	Closed	-$45K	–	1039
2015 Q2	$45K	Buy	+13,900	New	+$952K	﹤0.01%	674
2015 Q1	–	Sell	-65,400	Closed	-$93K	–	931
2014 Q4	$93K	Sell	65,400 -148,500	-69%	-$10.6M	﹤0.01%	646
2014 Q3	$254K	Buy	213,900 +58,300	+37%	+$4.27M	0.01%	556
2014 Q2	$232K	Buy	+155,600	New	+$11.2M	0.01%	561

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

HAP Trading's AZN Position: Q3 2025 in Review

HAP Trading reduced its AstraZeneca (AZN) stake by 57% in Q3 2025, selling an estimated $1.93M and leaving 9,483 shares worth $1.45M. The position accounts for 0.1% of the portfolio, ranked #131.

HAP Trading first reported a position in AZN in Q2 2013 and has held it in 27 quarters since. The position peaked at $18.8M in Q1 2017. 1,288 funds tracked by Wall St. Rank hold AZN as of Q3 2025.

HAP Trading held 9,483 shares of AstraZeneca worth $1.45M as of Q3 2025.
HAP Trading sold 12,784 AstraZeneca shares in Q3 2025, an estimated $1.93M.
AstraZeneca made up 0.1% of HAP Trading's portfolio in Q3 2025, its #131 holding.
HAP Trading first reported a position in AstraZeneca in Q2 2013 and has held it in 27 quarters since.
HAP Trading's AstraZeneca position peaked at $18.8M in Q1 2017.
1,288 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2025.

Based on HAP Trading's 13F filing for Q3 2025, filed 12 Nov 2025.